INDP: Indaptus Therapeutics Inc Kompaniya qiymatining sof foydaga nisbati
Indaptus Therapeutics (INDP) ulkan biotexnologiya sektori doirasidagi onkologiya markazlari va tadqiqot institutlarini nishonga olgan holda, saratonni davolashning universal usullarini ishlab chiqishga e'tibor qaratadi. Kompaniya hozirda o'z molekulalarining birlamchi sinovlarini o'tkazmoqda va faoliyat doirasini tadqiqot ittifoqlari bilan cheklamoqda. Aktivning bozor dinamikasi -24.90 miqdoridagi individual P/E ko'rsatkichini aks ettiradi. Biznesning muvaffaqiyati bakterial vektorlarning samaradorligiga, patent tozaligiga va R&D investitsiyalariga kirish imkoniyatiga bog'liq.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwbxec28.yq-7cu2wow&start=20220704&end=20261111&filename=GURU_Markets_-_INDP_-_Indaptus-Therapeutics_-_PE-Multiple "INDP: Indaptus Therapeutics Biznesning o‘zini qoplash muddati 04.07.2022 - 11.11.2026 | 👁️GURU.Markets👁️")
Indaptus (INDP) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Indaptus Therapeutics|INDP - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Indaptus Corp|INDP - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Indaptus Therapeutics, Inc.|INDP - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Indaptus Therapeutics|Oraliq qoplama koeffitsiyenti indaptusrx.com
- foyda va bozor multiplikatorlari tafsilotlari:
INDP - Kompaniyaning sof foydasi|Sof foyda prognozi Indaptus Therapeutics|INDP - P/E multiplikatori|Narxning kelajakdagi foydaga nisbati Indaptus Therapeutics Inc|INDP - PEG multiplikatori|EV/EBITDA multiplikatori Indaptus Therapeutics, Inc.|INDP - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bitta aksiya uchun foyda Indaptus Therapeutics|INDP - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sish sur'ati indaptusrx.com|INDP - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Indaptus Therapeutics
Kompaniyaning har tomonlama tahlili:indaptusrx.com INDP
Uzoq muddatli portfelni shakllantirishda fundamental skrining investitsiyalarning qoplash muddatlarini tanqidiy tahlil qilishni talab qiladi. Narx-foyda koeffitsiyenti kelajakdagi o'sish uchun premiumni o'lchash orqali biznesning qoplash muddatini belgilaydi. Indaptus Therapeutics (INDP) uchun ushbu metrika FDA tasdig'igacha daromad yo'qligi sababli o'zining klassik ma'nosini yo'qotadi. Kompaniyaning bozor P/E darajasini tahlil qilish orqali investor faqat biotexnologik aktivlarning spekulyativ qiymatini baholaydi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Bio - P/E multiplikatori|Biznesning o‘zini qoplash muddati Tourmaline TRML|Precigen, Inc. (PGEN) - Narxning foydaga nisbati|Narx-foyda multiplikatori PHAR|NKTR (Nektar Therapeutics Inc.) - P/E multiplikatori|Narx-foyda multiplikatori UPB (Upstream Bio, Inc.)|P/E multiplikatori ZBIO|P/E multiplikatori Immunome Bio (IMNM)|Narxning foydaga nisbati Gossamer Bio, Inc. GOSS|KALV (kalvista.com) - Kapitalizatsiyaning sof foydaga nisbati|SEPN: Narx-foyda koeffitsiyenti|Pieris Pharma - Bozor narxining sof foydaga nisbati|SVRA (Savara Corp) - Narx-foyda koeffitsiyenti|Rigel Corp (RIGL) - P/E multiplikatori|Narxning foydaga nisbati AnaptysBio, Inc.|astriatx.com (ATXS) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti ENGN (enGene)|RAPT (RAPT Therapeutics Inc.) - Kompaniya qiymatining sof foydaga nisbati|Aerovate Therapeutics - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati ACRS (Aclaris Therapeutics, Inc)|Kyverna Therapeutics - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati TLSA (tizianalifesciences.com)|CABA: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Ventyx Biosciences Inc. (VTYX)|Narxning foydaga nisbati Theratechnologies Inc|AVTX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ELDN|P/E multiplikatori agenusbio.com (AGEN)|Narxning foydaga nisbati Climb Bio CLYM|ZURA (Zura Bio Ltd) - Kapitalizatsiyaning sof foydaga nisbati|aTyr - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Adagene|IMA (ikenaoncology.com) - Narx-foyda koeffitsiyenti|Shattuck Labs (STTK) - P/E multiplikatori|Narx-foyda koeffitsiyenti EQ|CNTB (Connect Pharma) - Bozor narxining sof foydaga nisbati|P/E multiplikatori IMUX|Biznesning o‘zini qoplash muddati atarabio.com|P/E multiplikatori IFRX (InflaRx)|XFOR - Narx-foyda koeffitsiyenti|ACET - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Celularity Inc. CELU|INMB: P/E multiplikatori|BRNS - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Kezar Life Sciences|Narx-foyda multiplikatori SABS (sabbiotherapeutics.com)|P/E multiplikatori AKTX|enlivex.com - Narx-foyda multiplikatori|Narxning foydaga nisbati Q32 Bio QTTB|GOVX (GeoVax Corp) - Kapitalizatsiyaning sof foydaga nisbati|EDSA - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati IBIO|CARM: P/E multiplikatori|XTL Biopharmaceuticals Ltd - Kompaniya qiymatining sof foydaga nisbati|BOLT (Bolt Biotherapeutics Inc.) - P/E multiplikatori|P/E multiplikatori HCW Biologics Inc|Narxning foydaga nisbati Aptevo Therapeutics (APVO)|AIM (AIM ImmunoTech, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Aditxt, Inc. ADTX|GRI - Narx-foyda koeffitsiyenti|XORTX - P/E multiplikatori|HIND - P/E multiplikatori|REVB (Revelation Biosciences) - Narx-foyda koeffitsiyenti|scinai.com - Kompaniya qiymatining sof foydaga nisbati|CALI (CalciMedica Inc) - P/E multiplikatori|Affimed Therapeutics (AFMD) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Allakos Inc. (ALLK)|Narx-foyda koeffitsiyenti hookipapharma.com HOOK|Narxning foydaga nisbati IGM Biosciences IGMS|ITOS - Narx-foyda koeffitsiyenti|OCEA: Narx-foyda koeffitsiyenti|TCBP - P/E multiplikatori|Third Harmonic Bio, Inc (THRD) - Narxning foydaga nisbati
